Alpha Centric Advisors LLC has filed its 13F form on January 31, 2025 for Q4 2024 where it was disclosed a total value porftolio of $97.4 Million distributed in 212 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $4.74M, Unitedhealth Group Inc with a value of $3.6M, Johnson & Johnson with a value of $2.63M, Ishares Barclays 1 3 Year Trea with a value of $2.39M, and Abb Vie Inc. with a value of $2.31M.

Examining the 13F form we can see an decrease of $20.8M in the current position value, from $118M to 97.4M.

Alpha Centric Advisors LLC is based out at San Juan, PR

Below you can find more details about Alpha Centric Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $97.4 Million
Healthcare: $53.8 Million
ETFs: $15.7 Million
Real Estate: $6.71 Million
Financial Services: $5.84 Million
Technology: $4.79 Million
Industrials: $4.61 Million
Consumer Cyclical: $2.62 Million
Energy: $1.74 Million
Other: $1.53 Million

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 212
  • Current Value $97.4 Million
  • Prior Value $118 Million
  • Filing
  • Period Q4 2024
  • Filing Date January 31, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 66 stocks
  • Additional Purchases 32 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 105 stocks
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.